Navigation Links
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/6/2012

pany and our ongoing efforts to manage expenses.

Collaborative profit sharing, which represents Lilly's share of the gross margin for BYETTA, was $43.1 million for the quarter ended December 31, 2011, compared to $63.1 million for the same period in 2010. The decrease is due primarily to the termination of the Lilly collaboration resulting in the termination of gross profit sharing with Lilly in the U.S. effective December 1, 2011.

Net costs to reacquire economic interest in exenatide products totaled $431.6 million and consist primarily of reacquired marketing rights for unapproved products in the U.S. and are offset by gains associated with the termination of the collaboration with Lilly.  

Interest and other expense, net, increased to $31.7 million for the quarter ended December 31, 2011 from $8.9 million for the same period in 2010. The increase primarily reflects increased interest expense on the Company's debt, resulting from the promissory note related to the revenue sharing obligation (RSO) entered into in connection with the Settlement Agreement, and a loss on a fair value adjustment to a derivative asset.

Non-GAAP operating income was $17.6 million for the quarter ended December 31, 2011 compared to $22.9 million for the same period in 2010. GAAP net loss was $461.5 million, or $3.15 per share, for the quarter ended December 31, 2011, compared to GAAP net loss of $19.2 million, or $0.13 per share, for the same period in 2010.

Year Ended December 31, 2011Total revenues for the twelve months ended December 31, 2011 were $650.7 million. This includes net product sales of $621.6 million, including $517.7 million for BYETTA and $103.9 million for SYMLIN. This compares to net product sales of $651.1 million, consisting of $559.3 million for BYETTA and $91.8 million for SYMLIN for the same period in 2010.

Revenues under collaborative agreements were $29.1 million for the twelve months ended December 31, 2011, and
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... DUBLIN , Mar. 30, 2015 Research and ... addition of the "An Introduction to the Medical ... This seminar provides a detailed introduction to the European ... which products are covered, the involvement of Notified Bodies, ... must do. It will also cover the documentation necessary ...
(Date:4/1/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... medical paper has been published describing the positive ... with severe dry eye.  The results met key ... stated that statistically significant differences in both signs ... at various time points throughout the study.  Of ...
(Date:4/1/2015)... , April 1, 2015  Salix Pharmaceuticals, ... Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX:VRX), ... the outstanding $750,000,000 aggregate principal amount of its ... U8639TAA3 (the " Notes ") pursuant to two ... $262,500,000 aggregate principal amount of the Notes, and ...
Breaking Medicine Technology:An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 3Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3
... 15, 2010 UBM Medica announced today that it ... and iPad application which enhances physicians, clinical proficiency ... the popular DermClinic and PhotoClinic sections found on ... care clinicians, all specially selected by the Consultant ...
... FRANKLIN LAKES, N.J., Nov. 15, 2010 Tim Wentworth, ... Health Solutions, Inc. (NYSE: MHS ), is ... Annual Healthcare Conference on Wednesday, November 17, 2010 in ... http://www.newscom.com/cgi-bin/prnh/20100609/MEDCOLOGO) The presentation at The St. Regis ...
Cached Medicine Technology:UBM Medica Announces PhotoClinic Mobile App for iPhone and iPad 2UBM Medica Announces PhotoClinic Mobile App for iPhone and iPad 3Medco to Present at the Lazard Capital Markets 7th Annual Healthcare Conference 2
(Date:4/1/2015)... SCI Solutions , the health industry’s leading ... CEO Joel French will be a featured speaker at ... in Chicago, April 12-16, 2015. French will co-present “ ... Strategies ” with Northeast Georgia Health System (NGHS) on ... 38,000 healthcare industry professionals are expected at the conference, ...
(Date:4/1/2015)... Parents of teenaged and adolescent children might want ... post discusses Teen Violence Related to Substance Abuse. As ... Awareness Month, the substance abuse treatment center has issued ... identify if there may be problems with their kids ... alcohol. , “People learn how to establish healthy relationships ...
(Date:4/1/2015)... Tempaper has joined forces with the ... campaign that will raise critical funds to help save ... across the United States. , Throughout the month of ... will automatically receive free domestic ground shipping on ... needed progress to children and adults affected by muscular ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Aging2.0 ... care, today announces the launch of the Aging2.0 ... senior care stakeholders and technology companies. The announcement was ... (NIC) Capital and Business Strategies Forum in San ... the new Alliance program is now open for additional ...
(Date:4/1/2015)... Health Advocate™, Inc., the nation’s leading healthcare ... Corporation, today launched its new Health and Wellness Blog. ... the Health Advocate member website, features timely and reliable ... , “We’re pleased to introduce this new blog and ... Rosen, Executive Vice President, Health Advocate. “The blog is ...
Breaking Medicine News(10 mins):Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Health Advocate Launches New Health and Wellness Blog 2
... back we had carried a story about Wal-mart’s foray into ... pilot project which involved the lease of medical space in ... functioning at the Wal mart stores across 12 different states. ... World Health Care Congress, Leo Scott, the President and CEO ...
... discloses that nearly 65% of children from grade 7 to ... using artificial tanning equipments. ,The society is voicing ... under the age of 18 be prevented from tanning using ... is one of the most common forms of cancer in ...
... team of researchers at the John Hopkins Hospital in the US ... the PSA to detect prostate cancer.// ,The new test ... a simple blood test. ,Prostate cancer, the most ... of medicine. Physicians are unsure how to find it and when ...
... does not protect older women against cognitive decline, finds ... ,Identifying ways to prevent dementia is a public health ... may protect against dementia, but data from randomised studies ... US decided to test the effect of long term ...
... it is willing to proceed with the registration of a ... the Thai// government will halt its plans for a compulsory ... and will sell it to the Thai government for $1000 ... with the Thai government since January 2007, when plans for ...
... that took place last week at the Virginia Tech Many ... to formulate some// measures to avert this kind of a ... mentally ill, before they harm themselves and the others. A ... parents without the fear of infringing the privacy laws if ...
Cached Medicine News:Health News:Artificial Tanning Causes Concern 2Health News:New blood test to detect prostate cancer 2Health News:Abbott Offers Aluvia to Thailand in Return for Compulsory Licensing Halt 2Health News:Measures Needed to Avert Another Bloodbath 2
... GE Medical Systems ... to see for yourself ... Centricity Physician Office - ... Practice Manager) can simplify ...
... 3Z slit lamp is designed to for ... ready slit lamp offers the popular horizontal ... to the ReSeeVit family of slit lamps ... market to capture clear, crisp digital images ...
The AIA-600 II has become the new standard in benchtop immunoassay analyzers....
... PSA Semi-Quantitative Prostate Specific Antigen Rapid Test ... flow tests in strip and device formats ... Antigen (PSA). The tests are available with ... and all come with a 10 ng/mL ...
Medicine Products: